LSU Health Sciences Center; Children's Hospital

New Orleans, Louisiana 70118

0 studies enrolling now · 2 studies all time

What they study most

Primary Immunodeficiency Diseases (PID), Primary Refractory Neuroblastoma

Studies at this site

• Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD — Completed
• A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients — Stopped early